Second team finds natural super flu fighter
WASHINGTON (Reuters) - An antibody being developed by a Dutch drug company chokes off both seasonal flu and the H5N1 avian flu virus and might offer a way to develop better treatments and vaccines, researchers reported on Thursday.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=E10sWITSAmo:H_19BlEa9rg:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?i=E10sWITSAmo:H_19BlEa9rg:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=E10sWITSAmo:H_19BlEa9rg:F7zBnMyn0Lo) <img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?i=E10sWITSAmo:H_19BlEa9rg:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=E10sWITSAmo:H_19BlEa9rg:V_sGLiPBpWU)
</div><img src="http://feeds2.feedburner.com/~r/reuters/healthNews/~4/E10sWITSAmo" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/E10sWITSAmo/idUSTRE51P6M220090226